Population Distribution of CES1 Genetic Variants
Treatment-resistant hypertension is a widespread issue affecting individuals throughout the world. CES1 is a phase-1 drug-metabolizing enzyme responsible for hydrolyzing multiple medications, with Angiotensin-Converting Enzyme (ACE) inhibitors being one drug class affected. Genetic variations in the structure of CE...